Hepatitis A is a temporary liver infection caused by the hepatitis A virus. Symptoms include diarrhea, dark urine, fatigue, fever, nausea, vomiting, pain, and jaundice, yellowing of the eyes and skin.

In a pair of articles published in Lancet Gastroenterology & Hepatology, scientists lay out the case for why we should expand treatment recommendations for people with hepatitis B. Commissioned by the ...

Researchers suggest adding a new drug boceprevir to a two-drug treatment can enhance outcomes for hepatitis C patients, according to a USA Today news report. The drugs currently used to treat ...

According to the Centers for Disease Control and Prevention, more than 2 million people in the U.S. are infected with hepatitis C. The bloodborne illness attacks the liver and can lead to cancer or ...

U.S. Hepatitis B Treatment Market is Projected to Grow from USD 1.00 Billion in 2025E to USD 1.54 Billion by 2033 Owing to Strong Screening ProgramsAustin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- According ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. LEWISTON — Looking back, Rosie Boyce does not recall experiencing many ...

(Reuters) - A trio of oral medicines from Abbott Laboratories Inc to treat hepatitis C produced unprecedented cure rates in patients who had failed to benefit from standard treatment, as well as very ...

Background and aims The rate of functional cure (HBsAg loss) remains unsatisfactory following pegylated interferon (PEG-IFN) treatment in chronic hepatitis B. To optimize PEG-IFN administration, this ...

Millions of Americans live with chronic hepatitis and may not know it, because it can take years to become symptomatic. The most common types of the virus, hepatitis B and C, can lead to liver failure ...